ATRX and neuroblastoma: A limited number of genetic alterations have been identified as drivers of neuroblastoma, including somatic ATRX gene alterations which are identified in 10 % of high-risk neuroblastomas and define a distinct sub-group of patients with chronic, slowly progressive disease [[1], [2], [3]].